Cargando…

Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment

BACKGROUND: Tasquinimod (a quinoline-3-carboxyamide) is a small molecule immunotherapy with demonstrated effects on the tumor microenvironment (TME) involving immunomodulation, anti-angiogenesis and inhibition of metastasis. A target molecule of tasquinimod is the inflammatory protein S100A9 which h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olsson, Anders, Nakhlé, Jessica, Sundstedt, Anette, Plas, Pascale, Bauchet, Anne-Laure, Pierron, Valérie, Bruetschy, Luce, Deronic, Adnan, Törngren, Marie, Liberg, David, Schmidlin, Fabien, Leanderson, Tomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678646/ https://www.ncbi.nlm.nih.gov/pubmed/26673090 http://dx.doi.org/10.1186/s40425-015-0098-5

Ejemplares similares

Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer
por: Nakhlé, Jessica, et al.
Publicado: (2016)

The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth
por: Deronic, Adnan, et al.
Publicado: (2016)

Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth
por: Deronic, Adnan, et al.
Publicado: (2016)

Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment
por: Isaacs, John T., et al.
Publicado: (2014)

Mechanisms of action of tasquinimod on the tumour microenvironment
por: Raymond, E., et al.
Publicado: (2013)

Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
por: Olsson, Anders, et al.
Publicado: (2010)

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
por: Fan, Rong, et al.
Publicado: (2023)

A review of tasquinimod in the treatment of advanced prostate cancer
por: Williamson, Stuart Charles, et al.
Publicado: (2013)

Common Interactions between S100A4 and S100A9 Defined by a Novel Chemical Probe
por: Björk, Per, et al.
Publicado: (2013)

Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer
por: Gupta, Neha, et al.
Publicado: (2014)

S100A9 Interaction with TLR4 Promotes Tumor Growth
por: Källberg, Eva, et al.
Publicado: (2012)

CD11b(+)Ly6C(++)Ly6G(-) cells show distinct function in mice with chronic inflammation or tumor burden
por: Källberg, Eva, et al.
Publicado: (2012)

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer
por: Bratt, O, et al.
Publicado: (2009)

Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
por: Hägerbrand, Karin, et al.
Publicado: (2022)

Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer: A meta-analysis of randomized controlled trials
por: Gong, Ping, et al.
Publicado: (2018)

N-substituted benzamides inhibit NFκB activation and induce apoptosis by separate mechanisms
por: Liberg, D, et al.
Publicado: (1999)

Antifibrotic therapy to normalize the tumor microenvironment
por: Hauge, Anette, et al.
Publicado: (2020)

Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse
por: Tahvili, Sahar, et al.
Publicado: (2018)

Tumor−associated macrophage polarization in the inflammatory tumor microenvironment
por: Zou, Zijuan, et al.
Publicado: (2023)

Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
por: Björk, Per, et al.
Publicado: (2009)

Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid Cells
por: Chakraborty, Paramita, et al.
Publicado: (2015)

S100A9 and tumor growth
por: Leanderson, Tomas, et al.
Publicado: (2012)

Macrophage Polarization States in the Tumor Microenvironment
por: Boutilier, Ava J., et al.
Publicado: (2021)

The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo
por: Deronic, Adnan, et al.
Publicado: (2021)

The Tumor Targeted Superantigen ABR-217620 Selectively Engages TRBV7-9 and Exploits TCR-pMHC Affinity Mimicry in Mediating T Cell Cytotoxicity
por: Hedlund, Gunnar, et al.
Publicado: (2013)

Biological Effects of Nanoparticles on Macrophage Polarization in the Tumor Microenvironment
por: Reichel, Derek, et al.
Publicado: (2019)

Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment
por: Wang, Shilin, et al.
Publicado: (2022)

Tumor Microenvironment
por: Arneth, Borros
Publicado: (2019)

Computational Modeling of the Crosstalk Between Macrophage Polarization and Tumor Cell Plasticity in the Tumor Microenvironment
por: Li, Xuefei, et al.
Publicado: (2019)

The effect of acute exercise on interleukin-6 and hypothalamic–pituitary–adrenal axis responses in patients with coronary artery disease
por: Mahmood, Zeid, et al.
Publicado: (2020)

The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
por: Nelson, Michelle H., et al.
Publicado: (2023)

Macrophages in Tumor Microenvironments and the Progression of Tumors
por: Hao, Ning-Bo, et al.
Publicado: (2012)

Role of Sphingosylphosphorylcholine in Tumor and Tumor Microenvironment
por: Park, Mi Kyung, et al.
Publicado: (2019)

Copper in the tumor microenvironment and tumor metastasis
por: Kamiya, Tetsuro
Publicado: (2022)

The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression
por: Wang, Huogang, et al.
Publicado: (2021)

Tumor Microenvironment in the Brain
por: Lorger, Mihaela
Publicado: (2012)

The Tumor Microenvironment and Cancer
por: Chen, Zhen, et al.
Publicado: (2014)

Inflammation in the Tumor Microenvironment
por: Lin, Qing, et al.
Publicado: (2018)

Tumor Microenvironment and Metabolism
por: Yang, Li V.
Publicado: (2017)

Efferocytosis in the tumor microenvironment
por: Werfel, Thomas A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g4ju2nb6gfm9n6jp7tc6jla72o